TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ANIX

Anixa Biosciences Inc

Healthcare · Biotechnology

2.80$ +6.2% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Anixa Biosciences Inc (ANIX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 92.5% of the shares are freely tradable; institutional investors hold 15.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 15.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 5.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 92.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 3.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 35Mio.

Largest Shareholders

Institutions

Institutions ANIX
Name Stake (%) Shares Change (%) Date
Vanguard Capital Management, LLC 3.80 1,314,982 +0.0 03/31/2026
Laird Norton Tyee Trust Co 1.64 566,327 -3.7 03/31/2026
UBS Group AG 1.60 551,637 +20.2 03/31/2026
Davidson D A & Co 1.56 539,272 +0.0 06/30/2026
Geode Capital Management, LLC 1.05 364,731 +3.9 03/31/2026
Vanguard Fiduciary Trust Co 0.55 191,074 +0.0 03/31/2026
Marshall Wace Asset Management Ltd 0.50 173,179 +327.0 03/31/2026
BlackRock Inc 0.49 170,103 +3.7 03/31/2026

Funds

Funds ANIX
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.71 936,927 +0.0 07/31/2026
Vanguard Institutional Extnd Mkt Idx Tr 1.02 353,878 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings ANIX
Person Role Shares Value As of Type
Titterton Lewis H jr Director 996,967 2,791,508 $ Sep 10, 2026 direct
Kumar Amit Chief Executive Officer 665,000 1,862,000 $ Sep 10, 2026 direct
Baskies Arnold M Director 135,572 379,602 $ Jul 27, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 10, 2026 Kumar Amit Chief Executive Officer Buy 3,000 2.75 8,250
Sep 10, 2026 Titterton Lewis H jr Director Buy 10,000 2.73 27,300
Sep 10, 2026 Kumar Amit Chief Executive Officer Buy 5,000 2.76 13,800
Jul 31, 2026 Kumar Amit Chief Executive Officer Buy 5,000 3.47 17,350
Jul 27, 2026 Baskies Arnold M Director Other 5,428 3.46 18,781
Jul 27, 2026 Baskies Arnold M Director Other 6,000 3.13 18,780
Jul 27, 2026 Kumar Amit Chief Executive Officer Buy 5,000 3.44 17,200
Jul 27, 2026 Kumar Amit Chief Executive Officer Buy 3,188 3.37 10,744
Jul 24, 2026 Kumar Amit Chief Executive Officer Buy 3,000 3.73 11,190
Jul 20, 2026 Kumar Amit Chief Executive Officer Buy 5,000 3.46 17,300
Jul 20, 2026 Titterton Lewis H jr Director Buy 12,000 3.47 41,640
Jul 15, 2026 Titterton Lewis H jr Director Buy 2,797 3.28 9,174
Jul 10, 2026 Kumar Amit Chief Executive Officer Buy 5,000 3.04 15,200

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?